Abstract
The invention relates to low molecular weight heparin used for treating and/or preventing liver fibrosis. For the low molecular weight heparin, the range of number-average molecular weight (Mn) is 2800-5000Da, the range of weight-average molecular weight (Mw) is 6100-13000Da, the range of optimal number-average molecular weight (Mn) is 3000-4500Da, the range of weight-average molecular weight (Mw)is 6200-12000Da, further, the range of optimal number-average molecular weight (Mn) is 3200-4400Da, the range of weight-average molecular weight (Mw) is 6300-11000Da, further, the range of optimal number-average molecular weight (Mn) is 3250-4200Da, and the range of weight-average molecular weight (Mw) is 6400-10500Da.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
